Hepatitis E Virus Infection in Blood Donors and Risk to Patients in the United States and Canada

被引:21
|
作者
Delage, Gilles [1 ]
Fearon, Margaret [2 ,3 ]
Gregoire, Yves [1 ]
Hogema, Boris M. [4 ]
Custer, Brian [5 ]
Scalia, Vito [2 ,3 ]
Hawes, Gordon [2 ,3 ]
Bernier, France [1 ]
Nguyen, Megan L. [6 ]
Stramer, Susan L. [6 ]
机构
[1] Hema Quebec, Montreal, PQ, Canada
[2] Canadian Blood Serv, Toronto, ON, Canada
[3] Canadian Blood Serv, Ottawa, ON, Canada
[4] Donor Med Res, Sanquin Blood Serv, Dept Blood Borne Infect, Amsterdam, Netherlands
[5] Vitalant Res Inst, San Francisco, CA USA
[6] Amer Red Cross, Sci Affairs, Gaithersburg, MD USA
关键词
Hepatitis E virus; Transfusion transmission; Cost effectiveness; Risk-based decision making; ORGAN TRANSPLANT RECIPIENTS; COST-EFFECTIVENESS; ZOONOTIC TRANSMISSION; TRANSFUSION; PREVALENCE; HEV; SEROPREVALENCE; ANTIBODIES; HOKKAIDO; HEALTH;
D O I
10.1016/j.tmrv.2019.05.017
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Hepatitis E virus (HEV) is the most common cause of acute hepatitis worldwide including large water-borne outbreaks, zoonotic infections and transfusion transmissions. Several countries have initiated or are considering blood donor screening in response to high HEV-RNA donation prevalence leading to transfusion-transmission risk. Because HEV transmission is more common through food sources, the efficacy of blood donor screening alone may be limited. HEV-nucleic acids in 101 489 blood donations in the United States and Canada were studied. A risk-based decision-making framework was used to evaluate the quantitative risks and cost-benefit of HEV-blood donation screening in Canada comparing three scenarios: no screening, screening blood for all transfused patients or screening blood for only those at greatest risk. HEV-RNA prevalence in the United States was one per 16 908 (95% confidence interval [CI], 1:5786-1:81987), whereas Canadian HEV-RNA prevalence was one per 4615 (95% CI, 1:2579-1:9244). Although 4-fold greater, Canadian HEV-RNA prevalence was not significantly higher than in the United States. Viral loads ranged from 20 to 3080 international units per mL; all successfully typed infections were genotype 3. No HEV-RNA false-positive donations were identified for 100 percent specificity. Without donation screening, heart and lung transplant recipients had the greatest HEV-infection risk (1:366962) versus kidney transplant recipients with the lowest (1:2.8 million) at costs of $225 546 to $561 810 per quality-adjusted life-year (QALY) gained for partial or universal screening, respectively. Higher cost per QALY would be expected in the United States. Thus, HEV prevalence in North America is lower than in countries performing blood donation screening, and if implemented, is projected to be costly under any scenario. (C) 2019 Elsevier Inc. All rights reserved.
引用
收藏
页码:139 / 145
页数:7
相关论文
共 50 条
  • [1] Risk factors for hepatitis C virus infection in United States blood donors
    Murphy, EL
    Bryzman, SM
    Glynn, SA
    Ameti, DI
    Thomson, RA
    Williams, AE
    Nass, CC
    Ownby, HE
    Schreiber, GB
    Kong, FH
    Neal, KR
    Nemo, GJ
    HEPATOLOGY, 2000, 31 (03) : 756 - 762
  • [2] Hepatitis E virus infection in Thai blood donors
    Intharasongkroh, Duangnapa
    Thongmee, Thanunrat
    Sa-nguanmoo, Pattaratida
    Klinfueng, Sirapa
    Duang-in, Ausanee
    Wasitthankasem, Rujipat
    Theamboonlers, Apiradee
    Charoonruangrit, Ubonwon
    Oota, Sineenart
    Payungporn, Sunchai
    Vongpunsawad, Sompong
    Chirathaworn, Chintana
    Poovorawan, Yong
    TRANSFUSION, 2019, 59 (03) : 1035 - 1043
  • [3] Hepatitis E Virus in the United States and Canada: Is It Time to Consider Blood Donation Screening?
    Bienz, Marc
    Renaud, Christian
    Liu, Jia Ru
    Wong, Philip
    Pelletier, Patricia
    TRANSFUSION MEDICINE REVIEWS, 2024, 38 (03)
  • [4] Risk Factors and Sources of Foodborne Hepatitis E Virus Infection in the United States
    Cossaboom, Caitlin M.
    Heffron, Connie L.
    Cao, Dianjun
    Yugo, Danielle M.
    Houk-Miles, Alice E.
    Lindsay, David S.
    Zajac, Anne M.
    Bertke, Andrea S.
    Elvinger, Franccois
    Meng, Xiang-Jin
    JOURNAL OF MEDICAL VIROLOGY, 2016, 88 (09) : 1641 - 1645
  • [5] Hepatitis E virus infection in an immigrant to the United States
    Smalley, DL
    Brewer, SC
    Dawson, GJ
    Kyrk, C
    Waters, B
    SOUTHERN MEDICAL JOURNAL, 1996, 89 (10) : 994 - 996
  • [6] FREQUENT HEPATITIS E VIRUS INFECTION IN DUTCH BLOOD DONORS
    Zaaijer, H. L.
    Slot, E.
    Molier, M.
    Hogema, B. M.
    VOX SANGUINIS, 2013, 105 : 58 - 58
  • [7] Hepatitis E virus infection in Hong Kong blood donors
    Tsoi, Wai-Chiu
    Zhu, Xiaomei
    To, Amanda Pui-Chi
    Holmberg, Jerry
    VOX SANGUINIS, 2020, 115 (01) : 11 - 17
  • [8] Current incidence and residual risk of hepatitis B infection among blood donors in the United States
    Zou, Shimian
    Stramer, Susan L.
    Notari, Edward P.
    Kuhns, Mary C.
    Krysztof, David
    Musavi, Fatemeh
    Fang, Chyang T.
    Dodd, Roger Y.
    TRANSFUSION, 2009, 49 (08) : 1609 - 1620
  • [9] Hepatitis E virus: Relevance in blood donors and risk groups
    Mateos, ML
    Camarero, C
    Lasa, E
    Teruel, JL
    Mir, N
    Baquero, F
    VOX SANGUINIS, 1999, 76 (02) : 78 - 80
  • [10] Hepatitis C Virus Infection in Indigenous Populations in the United States and Canada
    Bruce, Veronica
    Eldredge, Jonathan
    Leyva, Yuridia
    Mera, Jorge
    English, Kevin
    Page, Kimberly
    EPIDEMIOLOGIC REVIEWS, 2019, 41 (01) : 158 - 167